Cargando…

Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022

The most effective way to stop the spread of COVID-19 (coronavirus disease 2019) is to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and isolate those infected as soon as possible. More than 1000 types of molecular and antigen-based immunoassay tests to detect SARS-CoV-2 are no...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulawka, Lukasz, Kuzan, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775127/
https://www.ncbi.nlm.nih.gov/pubmed/36552015
http://dx.doi.org/10.3390/biomedicines10123259
_version_ 1784855567754330112
author Fulawka, Lukasz
Kuzan, Aleksandra
author_facet Fulawka, Lukasz
Kuzan, Aleksandra
author_sort Fulawka, Lukasz
collection PubMed
description The most effective way to stop the spread of COVID-19 (coronavirus disease 2019) is to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and isolate those infected as soon as possible. More than 1000 types of molecular and antigen-based immunoassay tests to detect SARS-CoV-2 are now commercially available worldwide. In this review, we present the possibilities of molecular diagnostics available in Poland in 2022. We provide a description of what samples have proven useful to confirm SARS-CoV-2 infection, we describe what methods are used, as well as what safeguards can and should be used to prevent false-negative and false-positive results, and finally we review the products that diagnostic laboratories have to choose from. We also describe diagnostic problems associated with the mutation of the virus.
format Online
Article
Text
id pubmed-9775127
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97751272022-12-23 Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022 Fulawka, Lukasz Kuzan, Aleksandra Biomedicines Review The most effective way to stop the spread of COVID-19 (coronavirus disease 2019) is to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and isolate those infected as soon as possible. More than 1000 types of molecular and antigen-based immunoassay tests to detect SARS-CoV-2 are now commercially available worldwide. In this review, we present the possibilities of molecular diagnostics available in Poland in 2022. We provide a description of what samples have proven useful to confirm SARS-CoV-2 infection, we describe what methods are used, as well as what safeguards can and should be used to prevent false-negative and false-positive results, and finally we review the products that diagnostic laboratories have to choose from. We also describe diagnostic problems associated with the mutation of the virus. MDPI 2022-12-15 /pmc/articles/PMC9775127/ /pubmed/36552015 http://dx.doi.org/10.3390/biomedicines10123259 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fulawka, Lukasz
Kuzan, Aleksandra
Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
title Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
title_full Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
title_fullStr Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
title_full_unstemmed Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
title_short Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
title_sort molecular diagnostic tools against sars-cov-2 in poland in 2022
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775127/
https://www.ncbi.nlm.nih.gov/pubmed/36552015
http://dx.doi.org/10.3390/biomedicines10123259
work_keys_str_mv AT fulawkalukasz moleculardiagnostictoolsagainstsarscov2inpolandin2022
AT kuzanaleksandra moleculardiagnostictoolsagainstsarscov2inpolandin2022